These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 21633918

  • 1. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X, Li B, Ye H, Long D.
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [Abstract] [Full Text] [Related]

  • 2. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J, Feng A, Sun J, Jiang Z, Zhang G, Wang K, Hu S, Qu X.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [Abstract] [Full Text] [Related]

  • 3. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [Abstract] [Full Text] [Related]

  • 4. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS.
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 9. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study.
    Thakur S, Singla A, Chawla Y, Rajwanshi A, Kalra N, Arora SK.
    Indian J Pathol Microbiol; 2011 Dec; 54(3):448-53. PubMed ID: 21934201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [Abstract] [Full Text] [Related]

  • 12. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q, Su H, Cui J, Wang B.
    Immunol Invest; 2012 Aug 01; 41(1):15-27. PubMed ID: 21563925
    [Abstract] [Full Text] [Related]

  • 13. Expression of CD4+CD25+CD127Low regulatory T cells and cytokines in peripheral blood of patients with primary liver carcinoma.
    Zhou W, Deng J, Chen Q, Li R, Xu X, Guan Y, Li W, Xiong X, Li H, Li J, Cai X.
    Int J Med Sci; 2020 Aug 01; 17(6):712-719. PubMed ID: 32218692
    [Abstract] [Full Text] [Related]

  • 14. [Changes of CD4+CD25+ regulatory T cells, IL-10 and TGF-beta1 levels in peripheral blood in children with asthma].
    Li M, Song L, Zhang JB, Fang J, Li L.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct 01; 11(10):829-32. PubMed ID: 19849943
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N, Kanto T, Itose I, Kuroda S, Inoue M, Matsubara T, Higashitani K, Miyazaki M, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    Int J Cancer; 2012 Dec 01; 131(11):2573-83. PubMed ID: 22419479
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.
    Br J Dermatol; 2008 Jun 01; 158(6):1197-209. PubMed ID: 18410422
    [Abstract] [Full Text] [Related]

  • 18. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ, Yang ZY, Zhang LD, Ping-Bie, Wang SG, Ma KS, Li XW, Dong JH.
    Hum Immunol; 2010 Dec 01; 71(12):1180-6. PubMed ID: 20870003
    [Abstract] [Full Text] [Related]

  • 19. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.
    Int Immunopharmacol; 2009 Jul 01; 9(7-8):831-6. PubMed ID: 19303058
    [Abstract] [Full Text] [Related]

  • 20. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC, Quéreux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dréno B.
    Exp Dermatol; 2010 Aug 01; 19(8):e95-102. PubMed ID: 19845755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.